008 |
|
200319s2020 ne o 000 0 eng d |
020 |
|
|a9780081012413 (electronic bk.)
|
020 |
|
|a0081012411 (electronic bk.)
|
020 |
|
|a9780081012109 (pbk.)
|
020 |
|
|a0081012101
|
040 |
|
|aUKMGB|beng|epn|cUKMGB|dOPELS|dUKAHL|dGZM|dEBLCP|dYDX|dOCLCF|dYDXIT
|
041 |
0
|
|aeng
|
050 |
4
|
|aRC159.A5
|
082 |
04
|
|a616.9362061|223
|
095 |
|
|aNF|tLCC|p|dRC159.A5|e|c
|
245 |
00
|
|aAntimalarial agents|h[electronic resource] :|bdesign and mechanism of action /|cedited by Graham Patrick.
|
260 |
|
|aAmsterdam :|bElsevier,|c2020.
|
300 |
|
|a1 online resource
|
504 |
|
|aIncludes bibliographical references and index.
|
505 |
0
|
|a1. History of malaria and its treatment -- 2. Knowing one's enemy: the Plasmodium parasite -- 3. The cinchona alkaloids and the aminoquinolines -- 4. Artemisinin and artemisinin-related agents -- 5. Agents acting on pyrimidine metabolism -- 6. Antimalarial agents acting on hemoglobin degradation -- 7. Plasmepsins as targets for antimalarial agents -- 8. Falcipains as drug targets in antimalarial therapy -- 9. Drug targets in the apicoplast -- 10. Drugs targeting mitochondrial functions -- 11. The Plasmodium falciparum proteasome as a drug target -- 12. Transferases and their inhibition -- 13. Kinases and kinase inhibitors -- 14. Miscellaneous agents of clinical interest -- 15. Inhibitors of purine and pyrimidine pathways -- 16. Miscellaneous targets
|
588 |
|
|aDescription based on CIP data; resource not viewed.
|
650 |
0
|
|aAntimalarials.
|
650 |
7
|
|aAntimalarials.|2fast|0(OCoLC)fst00810562
|
655 |
0
|
|aElectronic books.
|
655 |
4
|
|aElectronic books.
|
700 |
1
|
|aPatrick, Graham L.,|eeditor.
|
856 |
40
|
|uhttps://www.sciencedirect.com/science/book/9780081012109
|